R. Michael Kleine
President, CEO and a director of Miramar Labs, Inc.
R. Michael Kleine has been a director since December 2014. He has served as president, CEO and a director of Miramar Labs, Inc., a leading medical device manufacturer, since January 2014. Previously, Mr. Kleine served as the president and CEO of EndoGastric Solutions, Inc., a medical device manufacturer, where he continued to serve as its executive chairman of the board until September 2014. Mr. Kleine also serves as a director of ASLAN Pharmaceuticals Pte. Ltd., a pharmaceutical company, QT Vascular, a medical device company, and BioParadox Inc., a point-of-care biologic treatment company. Prior to EGS, Mr. Kleine served as the president, CEO and as a director of Biosensors International, a company focused on the interventional cardiology and critical care markets. Previously, Mr. Kleine served as the president and CEO of Microvention, Inc., a leading medical device company, until its acquisition by Terumo Corporation, at which point Mr. Kleine served as the President, CEO and chairman of the Microvention Division. Previously, Mr. Kleine served as a partner of Pharos LLC, a company focused on acquiring and developing core technologies, and as president and CEO of each of Thermo Cardiosystems Inc. and Sorin Biomedical Inc., both medical device manufacturers. Mr. Kleine also held numerous leadership roles with Baxter International Inc. Mr. Kleine holds a M.S. from Webster University and a B.A. in biological science from Missouri Valley College.